• Fri news: New Novo obesity prospect linked to psychiatric side effects. Summit beats Keytruda in NSCLC. DermaSensor skin cancer detection device. Astellas digital health product. Sanofi MS data. See more on our front page

Cue Health, Google's COVID-19 test provider, raises $200M in an IPO

Quote
cafead

cafead

Administrator
Staff member
  • cafead   Sep 27, 2021 at 11:12: AM
via J&J-backed Cue Health has raised $200 million through an initial public offering to fund work to scale up commercial and manufacturing infrastructure in support of its portable diagnostic platform.

article source
 

<



Similar threads

cafead
Cue Health wins $28M BARDA contract to develop rapid respiratory infection test
Replies
0
Views
139
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
Cue Biopharma downsizes to focus on autoimmune pipeline
Replies
0
Views
6
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
Trials cue up new use for Roche&#039;s eye disease drug Vabysmo
Replies
0
Views
124
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
Cue&#039;s IL-2-based Biologic Shows Early Promise in Head and Neck Cancer
Replies
0
Views
124
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
Cue the M&amp;A chatter: UniQure is scouting for a buyout deal as gene therapy field...
Replies
0
Views
248
Pharma/Biotech Companies - In the News
cafead
cafead
Top Bottom
Back
Quote